Portfolio Manager Factsheet
Wright Medical was higher after the device maker posted a solid quarter in the previous month and takeover speculation increased. Array Biopharma dropped over 20% after management decided to withdraw its new drug application for their novel treatment of melanoma, a form of skin cancer, from U.S. Food and Drug Administration.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.